Dr. Benjamin Michael Weissman, M.D. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 626-321-6317 |
News Archive
A study by researchers at the John Wayne Cancer Institute at Saint John's Health Center in a recent issue of Journal of Clinical Oncology identifies activation of the enzyme COX-2 in gastric cancer tumors as a prognostic indicator for poor outcome.
Before the music can begin, the harmonica teacher makes sure everyone is in position. "Sit up straight. Feet on the floor. Try to breathe from the belly," she says.
Evidence continues to mount that vaccination against COVID-19, most notably the Pfizer and Moderna vaccines, produces robust, durable protection in the vast majority of recipients.
Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.
› Verified 9 days ago